The estimated Net Worth of Janet Mary Fauls is at least $18.1 Tisíc dollars as of 13 March 2015. Janet Fauls owns over 15,000 units of Endologix stock worth over $18,133 and over the last 17 years Janet sold ELGX stock worth over $0.
Janet has made over 3 trades of the Endologix stock since 2012, according to the Form 4 filled with the SEC. Most recently Janet exercised 15,000 units of ELGX stock worth $65,400 on 13 March 2015.
The largest trade Janet's ever made was exercising 85,000 units of Endologix stock on 13 December 2012 worth over $243,950. On average, Janet trades about 12,091 units every 76 days since 2008. As of 13 March 2015 Janet still owns at least 82,422 units of Endologix stock.
You can see the complete history of Janet Fauls stock trades at the bottom of the page.
Janet's mailing address filed with the SEC is ENDOLOGIX, INC., 11 STUDEBAKER, IRVINE, CA, 92618.
Over the last 22 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott a Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: